Amyotrophic Lateral Sclerosis (ALS) Research, Treatment, and Assistance Act of 1997
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Amyotrophic Lateral Sclerosis (ALS) Research, Treatment, and Assistance Act of 1997 - Amends title II (Old Age, Survivors and Disability Insurance) of the Social Security Act (SSA) to provide for a waiver of the 24-month waiting period for Medicare coverage for individuals disabled by amyotrophic lateral sclerosis, also known as ALS or Lou Gehrig's Disease.
Amends SSA title XVIII (Medicare) to provide for Medicare coverage of any drug approved by the Food and Drug Administration for use in the treatment or alleviation of ALS-related symptoms.
Authorizes appropriations, in addition to any already available, for ALS research through the National Institutes of Health.
Referred to the Subcommittee on Health and Environment, for a period to be subsequently determined by the Chairman.
- Introduced in House Formatted Text PDF
Cite this page
U.S. Congress. (2026). H.R. 2009: Amyotrophic Lateral Sclerosis (ALS) Research, Treatment, and Assistance Act of 1997. 105th Congress. Open America. https://openamerica.io/bill/105-HR-2009/
"H.R. 2009: Amyotrophic Lateral Sclerosis (ALS) Research, Treatment, and Assistance Act of 1997." 105th Congress, 2026, Open America, https://openamerica.io/bill/105-HR-2009/.
H.R. 2009, 105th Cong. (2026), https://openamerica.io/bill/105-HR-2009/.
[H.R. 2009: Amyotrophic Lateral Sclerosis (ALS) Research, Treatment, and Assistance Act of 1997](https://openamerica.io/bill/105-HR-2009/)